Abacus Diagnostica Revenue and Competitors
Estimated Revenue & Valuation
- Abacus Diagnostica's estimated annual revenue is currently $155k per year.
- Abacus Diagnostica's estimated revenue per employee is $155,000
Employee Data
- Abacus Diagnostica has 1 Employees.
- Abacus Diagnostica grew their employee count by 0% last year.
Abacus Diagnostica's People
Name | Title | Email/Phone |
---|
Abacus Diagnostica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Abacus Diagnostica?
Abacus Diagnostica Oy is a Finnish molecular diagnostic company, which has commercialized its proprietary GenomEra® platform. GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx. Abacus' vision is to provide cost-effective and easy-to-use products to enable MDx also in resource and capability limited settings.
keywords:N/AN/A
Total Funding
1
Number of Employees
$155k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Abacus Diagnostica News
Becton Dickinson, Roche Diagnostics, 3M, Abacus Diagnostica, AdvanDX, Alere, Arlington Scientific, Atlas Genetics, Bio-Rad Laboratories,...
... Disease Biomarker Testing Market Report Covers Future Trends With Research 2022 to 2029 Abacus Diagnostica, ALPCO, Abbott Laboratories.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $1.1M | 11 | -21% | N/A |
#4 | $1.4M | 13 | -13% | N/A |
#5 | $1.6M | 15 | 25% | N/A |